[Source: Research & Innovation]
Glycoconjugate vaccines provide highly effective protection against disease. But so far, they have been developed by time-consuming trial and error. Now, an EU-funded project is building up knowledge and skills to better design these vaccines in a bid to bring treatments to patients faster and keep European pharmaceutical innovation competitive.
29
Mar
Research Headlines – Faster future vaccine design
Leave a Reply
You must be logged in to post a comment.